[MS8] Mini Symposium 8
Clinical Immunology

[MS8-4] Long-term safety and effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: results from the APeX-S study

Adrian Wu¹, Jonathan Peter², Avner Reshef³, Marcus Maurer⁴, Sorena Kiani⁵, Marcin Stobiecki⁶, Tamar Kinaciyan⁷, Emel Aygören-Pürsün⁸, Jessica Best⁹, Melanie Cornpropst⁹, Kusumam Joseph⁹, Eniko Nagy⁹, Sharon Murray⁹, William P Sheridan⁹, Henriette Farkas¹ (1.Centre for Allergy and Asthma, Hong Kong, 2.UCT Lung Institute, South Africa, 3.Barzilai Medical Center, Israel, 4.Charité-Universitätsmedizin Berlin, Germany, 5.Barts Health NHS Trust, UK, 6.Krakowie Centrum Alergologii, Poland, 7.Medical University of Vienna, Austria, 8.University Hospital Frankfurt, Goethe University, Germany, 9.BioCryst Pharmaceuticals, Inc, USA, 10.Semmelweis University, Hungary)